Angel Biotechnology
Text only | Site Map | Search 
Enlarge text: A A A 
 
News
 

Update on ReNeuron's Clinical Trial  28 Jan 2010

Angel notes the announcement made by ReNeuron stating that ReNeuron has received written confirmation from GTAC.




Recombinant Proteins

Cellular Therapies
& Stem Cells

Viruses

Antibodies